We are live on
!
Find out more
CCM
Cinctive Capital Management Portfolio holdings
AUM
$1.53B
1-Year Est. Return
48.83%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+48.83%
3 Year Est. Return
+143.95%
5 Year Est. Return
+199.46%
10 Year Est. Return
–
AUM
$2.04B
AUM Growth
-$97.4M
(-4.6%)
Cap. Flow
-$113M
Cap. Flow
% of AUM
-5.55%
Top 10 Holdings %
Top 10 Hldgs %
11.33%
Holding
698
New
210
Increased
118
Reduced
125
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$18.9M |
| 2 |
Baxter International
BAX
|
+$18.2M |
| 3 |
EXE
Expand Energy Corp
EXE
|
+$17M |
| 4 |
T-Mobile US
TMUS
|
+$16.5M |
| 5 |
Merck
MRK
|
+$16.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$22.2M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$21M |
| 3 |
Paycom
PAYC
|
+$19.5M |
| 4 |
Canadian Natural Resources
CNQ
|
+$14.1M |
| 5 |
Gilead Sciences
GILD
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.02% |
| 2 | Technology | 17.87% |
| 3 | Consumer Discretionary | 12.08% |
| 4 | Financials | 10% |
| 5 | Energy | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CALL
Salesforce
CRM
$133B
| $35.3M | 1.73% |
+130,000
| New | +$33M |
|
|
CTRA
2
CALL
DELISTED
Coterra Energy
CTRA
| $33.7M | 1.65% |
+1,550,000
| New | +$26.6M |
|
3
CALL
AbbVie
ABBV
$448B
| $27M | 1.32% |
+250,000
| New | +$28.6M |
|
4
UnitedHealth
UNH
$392B
| $20.8M | 1.02% |
53,184
-14,529
| -21% | -$6.02M |
|
5
Avantor
AVTR
$7.48B
| $20M | 0.98% |
489,587
-30,001
| -6% | -$1.17M |
|
|
6
Salesforce
CRM
$133B
| $19.8M | 0.97% |
73,107
-713
| -1% | -$181K |
|
|
7
Thermo Fisher Scientific
TMO
$196B
| $19.7M | 0.96% |
+34,421
| New | +$18.9M |
|
|
EXE
8
Expand Energy Corp
EXE
$22.3B
| $18.7M | 0.92% |
+303,802
| New | +$17M |
|
|
9
Baxter International
BAX
$11.2B
| $18.6M | 0.91% |
+230,853
| New | +$18.2M |
|
10
CALL
Advanced Micro Devices
AMD
$901B
| $18M | 0.88% |
+175,000
| New | +$17.9M |
|
11
General Motors
GM
$74.1B
| $17M | 0.83% |
323,284
+162,403
| +101% | +$8.63M |
|
|
HZNP
12
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $16.6M | 0.81% |
151,235
+7,605
| +5% | +$789K |
|
|
13
Merck
MRK
$315B
| $16.1M | 0.79% |
+214,690
| New | +$16.3M |
|
|
14
Advanced Micro Devices
AMD
$901B
| $16.1M | 0.79% |
156,339
-24,637
| -14% | -$2.52M |
|
|
15
T-Mobile US
TMUS
$207B
| $15.1M | 0.74% |
+118,201
| New | +$16.5M |
|
|
16
CALL
Merck
MRK
$315B
| $15M | 0.74% |
+200,000
| New | +$15.2M |
|
|
PXD
17
DELISTED
Pioneer Natural Resource Co.
PXD
| $14.9M | 0.73% |
+89,710
| New | +$13.6M |
|
|
18
AbbVie
ABBV
$448B
| $14.6M | 0.72% |
135,427
-8,327
| -6% | -$951K |
|
|
CTRA
19
DELISTED
Coterra Energy
CTRA
| $14.5M | 0.71% |
666,719
+187,502
| +39% | +$3.22M |
|
|
KAHC
20
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
| $14.4M | 0.71% |
1,479,579
| – | – |
|
|
ZEN
21
DELISTED
ZENDESK INC
ZEN
| $14.4M | 0.7% |
123,755
+47,107
| +61% | +$6.09M |
|
|
VEI
22
DELISTED
Vine Energy Inc.
VEI
| $14.2M | 0.69% |
860,594
+302,146
| +54% | +$4.53M |
|
23
SES AI
SES
$218M
| $13.5M | 0.66% |
1,364,723
| – | – |
|
24
Envista
NVST
$4.3B
| $13.3M | 0.65% |
318,588
+233,153
| +273% | +$9.83M |
|
|
BOAC
25
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
| $13.2M | 0.65% |
1,348,291
+614,004
| +84% | +$6.01M |
|
Similar funds
MCP
ICM
FI
GHC
FBB
SG
CET
HR
Cinctive Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Cinctive Capital Management held 698 positions worth $2.04B, down 4.6% from $2.14B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Cinctive Capital Management withdrew a net $113M in Q3 2021, closing 177 positions and reducing 125 holdings. Its most notable exit was Canadian Natural Resources, an estimated $14.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Cinctive Capital Management opened a new position in Thermo Fisher Scientific worth $19.7M.
- Cinctive Capital Management's largest Q3 2021 buy was Thermo Fisher Scientific: 34,421 shares worth $19.7M.
- Cinctive Capital Management added most to Eli Lilly in Q3 2021, an estimated $11.2M increase.
- Cinctive Capital Management's biggest Q3 2021 reduction was Elevance Health, cutting an estimated $22.2M.
- Cinctive Capital Management fully exited Canadian Natural Resources in Q3 2021, selling an estimated $14.1M.
- Cinctive Capital Management's ten largest holdings make up 11% of its $2.04B portfolio in Q3 2021.
- Cinctive Capital Management opened 210 new positions and closed 177 in Q3 2021.
- Cinctive Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.04B.
Based on Cinctive Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.